As with all prior Sp2/0-derived hybridomas investigated by our group, the SP2 primer amplified the aberrant myeloma kappa chain, a well-described sequence which does not produce secreted light chain due to the presence of a key frameshift mutation [10]. The gene discussed is SP2; the disease is plasma cell myeloma.